All News

Reimbursement

Ready for Market – How Do We Get ATMPs Over the Line in Europe?
12 May 2023
Ready for Market – How Do We Get ATMPs Over the Line in Europe?
Join us as a panel
Top 10 Events in Cell & Gene Therapy 2022
18 January 2023
Top 10 Events in Cell & Gene Therapy 2022
It’s day 1 of Advanced
The Most Expensive Gene Therapy Approved by the FDA at $3.5M for Hemophilia B
23 November 2022
The Most Expensive Gene Therapy Approved by the FDA at $3.5M for Hemophilia B
Late-stage clinical trial company CellVax
bluebird bio’s Zynteglo Approved by the FDA for Beta-Thalassemia
24 August 2022
bluebird bio’s Zynteglo Approved by the FDA for Beta-Thalassemia
bluebird bio has announced that
POPULAR NEWS ITEMS
Image
8 June 2023

Eureka Therapeutics Awarded $10.6M CIRM Grant for T-Cell Therapy in Pediatric Liver Cancer

Image
7 June 2023

Cell and Gene Therapy Catapult Open New Edinburgh, UK, Facilities

Image
5 June 2023

BioCentriq® Unveils LEAP™ Advanced Therapy Platform, Enabling Rapid Patient Access for Early-Stage Biotech Companies

Market Access and Reimbursement Q&A with AviadoBio CEO Lisa Deschamps
21 June 2022
Market Access and Reimbursement Q&A with AviadoBio CEO Lisa Deschamps
Lisa Deschamps, AviadoBio CEO and
Market Access and Reimbursement Q&A with Nicola Redfern
21 June 2022
Market Access and Reimbursement Q&A with Nicola Redfern
Phacilitate's Advanced Therapies Europe speaker
Market Access and Reimbursement Q&A with Vice President of Novartis, Tay Salimullah
21 June 2022
Market Access and Reimbursement Q&A with Vice President of Novartis, Tay Salimullah
Market Access Report 2022
1 June 2022
Market Access Report 2022
The Phacilitate team explores market
Load more News
RECOMENDED TOPICS
Clinical Trials
Collaborations, Mergers & Acquisitions
Finance & Investment
Patient Access & Engagement
Regulatory & Standards
Reimbursement
Strategy
POPULAR NEWS ITEMS
Image

Eureka Therapeutics Awarded $10.6M CIRM Grant for T-Cell Therapy in Pediatric Liver Cancer

Image

Cell and Gene Therapy Catapult Open New Edinburgh, UK, Facilities

Image

BioCentriq® Unveils LEAP™ Advanced Therapy Platform, Enabling Rapid Patient Access for Early-Stage Biotech Companies